While an exact role of CD49c/CD29 interaction with galectin-3 is not described in human CD4 and CD8 αβ T cells, these interaction partners are responsible for the failure of Vδ2 T-cell proliferation in the presence of galectin-3 producing cells such as tumor cells. The gene discussed is ITGB1; the disease is neoplasm.